Second shot boosts protection for moderate-severe Covid-19 to 94 percent: JnJ Ruchika Sharma22 Sept 2021 10:00 AM ISTNew Delhi: Johnson & Johnson said Tuesday a second shot of its COVID-19 vaccine given about two months after the first increased its effectiveness...
Johnson and Johnson two-dose vaccine against Ebola safe, claims study MD Bureau16 Sept 2021 10:30 AM ISTLondon: The two-dose vaccine against Ebola virus developed by US drug maker Johnson and Johnson is safe, well tolerated and produces a strong immune...
Moderna COVID vaccine superior to Pfizer, JnJ against Delta, claims study MD Bureau11 Sept 2021 9:30 AM ISTNew York: Moderna's vaccine for Covid-19 is significantly more effective against the Delta variant of the SARS-CoV2 virus than Pfizer or Johnson &...
Covid-19: Aspen Pharmacare eyes Serum Institute model as it seeks licence to make JnJ vaccine Ruchika Sharma4 Sept 2021 9:00 AM ISTJohannesburg: South Africa's Aspen Pharmacare wants to model itself on India's Serum Institute by getting a licence to manufacture Johnson &...
JnJ HIV vaccine fails Imbokodo trial Ruchika Sharma1 Sept 2021 4:54 PM ISTThe Imbokodo study showed a 25.2% vaccine efficacy, based on which, the drugmaker said the study will not continue.
Second dose provides strong boost against Covid-19: JnJ MD Bureau27 Aug 2021 9:00 AM ISTWashington: The second dose of Johnson & Johnson's Covid-19 vaccine generates a strong immune response against the deadly virus among people...
ORS or not ORS? PIL seeks prohibition of JnJ ORSL brand questioning its composition Medical Dialogues Team25 Aug 2021 5:05 PM ISTNew Delhi: Alleging that Johnson and Johnson (JnJ) has been deceptively selling ORSL drinks as ORS health formula, a petition has been filed in the...
JnJ eyes CDSCO nod for single shot COVID vaccine trials in 12-17 year olds MD Bureau20 Aug 2021 11:40 AM ISTNew Delhi: The American-based pharma major Johnson & Johnson (J&J) has applied to the Central Drugs Standard Control Organisation (CDSCO)...
Johnson and Johnson Rilematovir gets CDSCO panel okay for phase 3 trial Medical Dialogues Team18 Aug 2021 4:18 PM ISTNew Delhi: Global pharmaceuticals major Johnson and Johnson (JnJ) has got a go ahead from the Subject Expert Committee (SEC) of the Central Drugs...
JnJ cancer drug Amivantamab gets CDSCO panel okay with waiver of local phase 3,4 trials Medical Dialogues Team14 Aug 2021 3:25 PM ISTNew Delhi: Considering an unmet medical need in the country, the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation...
JnJ gets DCGI emergency use approval for single dose COVID vaccine Ruchika Sharma7 Aug 2021 4:51 PM ISTNew Delhi: Johnson & Johnson's single-dose COVID-19 vaccine has been given Emergency Use approval in India, Union Health minister Mansukh...
Discussion between Govt, US manufacturers for procuring COVID vaccines not yet over: NTAGI Chief Ruchika Sharma3 Aug 2021 10:30 AM ISTNew Delhi: Discussions and negotiations are still not over between the government and US-based COVID-19 vaccine manufacturers for procuring their...
